We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

288 hedge funds and large institutions have $5.34B invested in Intra-Cellular Therapies Inc. in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 115 increasing their positions, 78 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more call options, than puts

Call options by funds: $16.6M | Put options by funds: $10.7M

47% more repeat investments, than reductions

Existing positions increased: 115 | Existing positions reduced: 78

42% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 36

38% more funds holding in top 10

Funds holding in top 10: 8 → 11 (+3)

18% more capital invested

Capital invested by funds: $4.55B → $5.34B (+$797M)

5% more funds holding

Funds holding: 274 → 288 (+14)

Holders
288
Holders Change
+14
Holders Change %
+5.11%
% of All Funds
4.52%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.17%
New
51
Increased
115
Reduced
78
Closed
36
Calls
$16.6M
Puts
$10.7M
Net Calls
+$5.94M
Net Calls Change
-$34M

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$36.7M
2
Holocene Advisors
Holocene Advisors
New York
+$36.1M
3
Macquarie Group
Macquarie Group
Australia
+$35.4M
4
NIP
Nicholas Investment Partners
California
+$31.1M
5
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$30.5M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$207M
2
WA
Wasatch Advisors
Utah
-$62M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$47.1M
4
DM
Deerfield Management
New York
-$39.7M
5
Citadel Advisors
Citadel Advisors
Florida
-$36.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
126
Citigroup
New York
$2.37M +$1.61M +25,832 +224%
Connor, Clark & Lunn Investment Management (CC&L)
127
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.34M +$71K +1,139 +3%
Stifel Financial
128
Stifel Financial
Missouri
$2.27M +$2.87K +46 +0.1%
1CM
129
1492 Capital Management
Wisconsin
$2.21M -$1.06K -17 -0%
Natixis Advisors
130
Natixis Advisors
Massachusetts
$2.14M +$398K +6,385 +23%
DA
131
Duality Advisers
Florida
$2.08M +$2.04M +32,805 New
EAM
132
EFG Asset Management
Oregon
$2.05M -$119K -1,912 -6%
OAM
133
Oppenheimer Asset Management
New York
$1.99M -$125K -1,998 -6%
EI
134
EAM Investors
California
$1.89M +$1.86M +29,789 New
BC
135
Brookfield Corp
Ontario, Canada
$1.86M -$4.04M -64,824 -69%
BCI
136
Brinker Capital Investments
Pennsylvania
$1.8M +$1.77M +28,359 New
OPS
137
Orion Portfolio Solutions
Nebraska
$1.8M +$1.77M +28,359 New
Susquehanna International Group
138
Susquehanna International Group
Pennsylvania
$1.78M -$705K -11,315 -29%
SO
139
STRS Ohio
Ohio
$1.71M +$393K +6,300 +30%
State Board of Administration of Florida Retirement System
140
State Board of Administration of Florida Retirement System
Florida
$1.68M -$118K -1,900 -7%
AA
141
AlphaCentric Advisors
Puerto Rico
$1.61M – – –
ONB
142
Old National Bancorp
Indiana
$1.59M -$73.1K -1,173 -4%
Point72 Asset Management
143
Point72 Asset Management
Connecticut
$1.59M -$13M -209,008 -89%
SG Americas Securities
144
SG Americas Securities
New York
$1.58M -$3.36M -53,936 -68%
EP
145
Edgestream Partners
New Jersey
$1.53M +$1.5M +24,106 New
Citadel Advisors
146
Citadel Advisors
Florida
$1.53M -$36.7M -589,663 -96%
ASRS
147
Arizona State Retirement System
Arizona
$1.53M -$38.1K -611 -2%
KOCAA
148
Knights of Columbus Asset Advisors
Connecticut
$1.5M +$3.24K +52 +0.2%
Teacher Retirement System of Texas
149
Teacher Retirement System of Texas
Texas
$1.47M -$187K -2,994 -11%
EAM
150
Erste Asset Management
Austria
$1.45M – – –
4 5
6
7 8

ITCI Hedge Fund Activity: Q2 2023 in Review

288 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2023, worth a combined $5.34B — up 18% from $4.55B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new ITCI positions and 36 closed out — a net gain of 15 holders — while 115 added to existing stakes and 78 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $36.7M. The largest seller was Wellington Management Group, cutting an estimated $207M.

  • 288 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2023, up from 274 in Q1 2023.
  • Funds reported $5.34B of Intra-Cellular Therapies Inc. stock for Q2 2023, up 18% quarter-over-quarter.
  • 51 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2023 and 36 closed out, a net change of +15 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q2 2023 was Lord, Abbett & Co, an estimated $36.7M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2023 was Wellington Management Group, an estimated $207M sold.

Based on aggregated 13F filings for Q2 2023.